Growth Metrics

Artivion (AORT) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn 46.64%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 46.64%
Dec 31, 2025 -665.92%
Sep 30, 2025 772.43%
Jun 30, 2025 316.22%
Mar 31, 2025 -99.04%
Dec 31, 2024 -117.01%
Sep 30, 2024 -46.20%
Jun 30, 2024 -78.79%
Mar 31, 2024 -6.91%
Dec 31, 2023 274.65%
Sep 30, 2023 262.13%
Jun 30, 2023 242.32%
Mar 31, 2023 -121.01%
Dec 31, 2022 65.64%
Sep 30, 2022 -90.91%
Jun 30, 2022 -117.96%
Mar 31, 2022 40.43%
Dec 31, 2021 -866.32%
Sep 30, 2021 121.71%
Jun 30, 2021 -108.34%
Mar 31, 2021 -121.04%
Dec 31, 2020 151.02%
Sep 30, 2020 -1,297.46%
Jun 30, 2020 5,894.64%
Mar 31, 2020 2,007.29%
Dec 31, 2019 -137.07%
Sep 30, 2019 -149.32%
Jun 30, 2019 38.21%
Mar 31, 2019 89.27%
Dec 31, 2018 152.97%
Sep 30, 2018 476.12%
Jun 30, 2018 72.49%
Mar 31, 2018 -769.58%
Dec 31, 2017 -421.68%
Sep 30, 2017 -79.27%
Jun 30, 2017 -369.36%
Mar 31, 2017 -72.02%
Dec 31, 2016 -142.08%
Sep 30, 2016 93.29%
Jun 30, 2016 -1.42%
Mar 31, 2016 948.73%
Dec 31, 2015 -131.31%
Sep 30, 2015 463.91%
Jun 30, 2015 225.30%
Mar 31, 2015 82.05%
Dec 31, 2014 -82.02%
Sep 30, 2014 -117.28%
Jun 30, 2014 -162.64%
Mar 31, 2014 -10.53%
Dec 31, 2013 278.38%
Sep 30, 2013 56.88%
Jun 30, 2013 117.79%
Mar 31, 2013 -694.19%
Dec 31, 2012 744.48%
Sep 30, 2012 205.07%
Jun 30, 2012 3.44%
Mar 31, 2012 -126.29%
Dec 31, 2011 -86.13%
Sep 30, 2011 124.20%